Ranger™ paclitaxel-coated balloon versus conventional balloon angioplasty for treatment of failing arteriovenous fistulas and grafts in haemodialysis patients: A retrospective cohort study.

Shereen Xue Yun Soon Ru Yu TanSuh Chien PangCharyl Jia Qi YapAnkur PatelApoorva GognaChieh-Suai TanTze Tec ChongTjun Y Tang

Published in: The journal of vascular access (2021)

Fistuloplasty with Ranger™ PCB for failing arteriovenous circuits in end-stage renal failure patients, is a safe and efficacious modality compared to POBA in terms of longer freedom from TLR.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
ejection fraction
prognostic factors
toll like receptor
inflammatory response
patient reported outcomes
replacement therapy